Oxycodonhydrochlorid 1 A Pharma (Oxycodone Hydrochloride)

Oxycodone Hydrochloride is used within the opioid analgesic pathway to treat pain of varying intensity.

• Acute postoperative pain: provides rapid relief of pain following surgical procedures.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: used when other analgesics are insufficient for long‑term pain management.
• Severe traumatic injury pain: reduces intense pain resulting from major injuries.
• Palliative care pain: alleviates pain in end‑of‑life care settings.

• Oxycodone Hydrochloride acts as a full agonist at the μ‑opioid receptors in the central nervous system. By binding to these receptors, it inhibits the transmission of nociceptive signals and modifies pain perception, producing analgesia. The drug also influences δ‑receptor activity, contributing to its overall analgesic effect while producing typical opioid‑related central nervous system effects.

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects

• Nausea and vomiting: mild to moderate gastrointestinal upset.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness or sedation: increased sleepiness or reduced alertness.
• Dizziness: sensation of light‑headedness or imbalance.
• Dry mouth: reduced salivary flow causing oral discomfort.
• Pruritus: mild itching without rash.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Opioid use disorder: risk of dependence, tolerance, and addiction.
• Seizures: rare occurrence of convulsive episodes.
• Anaphylaxis: acute allergic reaction with airway compromise.
• adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing oxycodone, clinicians should consider several safety measures.

• Assess pain severity and treatment goals: ensure opioid therapy is appropriate for the patient’s condition.
• Evaluate risk of respiratory depression: monitor breathing, especially after dose initiation or escalation.
• Review patient history for substance use disorder: identify potential for misuse or dependence.
• Adjust dose in renal or hepatic impairment: consider reduced clearance in organ dysfunction.
• Avoid concomitant CNS depressants: limit use with benzodiazepines or alcohol.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Oxycodone may interact with a range of medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Combined use with other strong opioids: increases risk of respiratory depression and profound sedation.
• Concurrent benzodiazepines or barbiturates: synergistic CNS depression can be fatal.
• CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): elevate oxy‑hydrochloride plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may reduce conversion to active metabolites, affecting analgesia.
• Anticholinergic agents: can worsen constipation and urinary retention.
• Diuretics: may enhance hypotensive effects, requiring blood pressure monitoring.